Form 4: Centessa Pharmaceuticals Officer Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Tia L. Bush, Chief Technology & Quality Officer of Centessa Pharmaceuticals, disposed of 6,419 ordinary shares to cover tax withholding obligations related to vesting restricted share units.
Summary
- On September 30, 2024, Tia L. Bush, Chief Technology & Quality Officer of Centessa Pharmaceuticals plc, disposed of 6,419 ordinary shares.
- The transaction was executed to cover tax withholding obligations associated with the vesting of restricted share units.
- The shares were disposed of at a price of $15.79 per share.
- Following the transaction, Bush directly owns 157,226 ordinary shares of Centessa Pharmaceuticals plc.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects a routine transaction for tax purposes and doesn't indicate a change in the officer's overall confidence in the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of transaction: Disposal of shares to cover tax obligations. |
| 10/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.